Arbutus Biopharma Corporation

(ABUS) Trade

By |

Profile

Arbutus Biopharma Corp is a pharmaceutical company. It discovers, develops and commercializes cure for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and also involved in licensing of Lipid nanoparticle technology.

Contact Information

Website: www.arbutusbio.com
Email: ir@arbutusbio.com
Main Phone: +1 604 419-3200
Address: 100 - 8900 Glenlyon Parkway
State: BC
City / Town: Burnaby
Country: CAN
Postal Code: V5J 5J8

Issuer Information

Exchange: NGS
CEO: Mark Murray
Employees: 130
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 4.38 $ -0.01 (-0.23%)
Last Price 4.38 Change $ -0.01 Change % -0.23 Tick N/A
Bid 4.21 Bid Size 100.00 Ask 6.30 Ask Size 300.00
Open 4.35 High 4.59 Low 4.33 Prev Close 4.39
Last Trade Volume 215,066 52 Wk Hi 12.60 52 Wk Low 4.01
Market Cap 243 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 55,477,235.00 EPS (TTM) -1.51 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 1 4
Number of Buys 1 1
Number of Sells 0 3
Net Activity 27007 -12993
Last 10 Buys Shares
Richard C. Henriques 1,000
Last 10 Sell Shares
Michael J. Sofia 1,000
Michael J. Sofia 1,000
Michael J. Sofia 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 10 10 10 9
Low Target Price Estimate 6 6 6 6
Mean Target Price Estimate 8.08 8.08 8.08 7.75
Standard Deviation 2.01 2.01 2.01 1.56
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 06/18/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.5 1.5 1.5 1.5